FACTORS ASSOCIATED WITH LONG-TERM FUNCTIONAL AND PSYCHOSOCIAL OUTCOMES IN PATIENTS WITH NON-HODGKIN LYMPHOMA

被引:0
|
作者
Amatya, Bhasker [1 ,2 ,3 ,4 ,6 ]
Dickinson, Michael [2 ,4 ,5 ]
Khan, Fary [1 ,2 ,3 ,4 ]
机构
[1] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Dept Rehabil Med, Parkville, Vic, Australia
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia
[3] Royal Melbourne Hosp, Australian Rehabil Res Ctr, Parkville, Vic, Australia
[4] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[6] Royal Melbourne Hosp, Dept Rehabil Med, Royal Pk Campus,34-54 Poplar Rd, Parkville, Vic 3050, Australia
关键词
non-Hodgkin lymphoma; rehabilitation; impair-ment; function; quality of life; QUALITY-OF-LIFE; LARGE B-CELL; CANCER REHABILITATION; UNMET NEEDS; HEALTH; SURVIVORS; SYMPTOMS; THERAPY; RETURN;
D O I
暂无
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To assess the long-term functional, psy-chosocial and participation outcomes in an Austra-lian cohort of non-Hodgkin lymphoma (NHL) survi-vors.Methods: A cross-sectional sample of adult NHL sur-vivors at the Peter MacCallum Cancer Centre (bet-ween 2015 and 2020), participated by completing validated questionnaires. A series of analyses des-cribed their current level of function, psychosocial well-being, and participation.Results: Of 129 participants (mean (M) +/- standard deviation (SD) age: 62.5 +/- 8.8 years), the majo-rity (58%) had aggressive NHL and grade III- IV (72%), with time since diagnosis of 4.6 +/- 1.2 years. Participants reported ongoing issues after completion of treatment: fatigue (63%), bladder dysfunction (61%), cognitive impairment (53%), and NHL-related pain (46%). Most made good functional recovery (M +/- SD) (Functional Indepen-dent Measure-Motor: 79.5 +/- 8.2), reported mini-mal change in their negative emotional states, and NHL-specific quality of life (QoL) (Functio-nal Assessment of Cancer Therapy-Lymphoma: 133.5 +/- 22.1). Participants were "well" adjusted to community living (Community Integration Mea-sure: 42.2 +/- 7.4) and satisfied with their current life (Satisfaction with Life Scale: 26.3 +/- 6.0). Fac-tors significantly associated with the poorer cur-rent level of function were: age at diagnosis < 60 years, time since NHL diagnosis > 4.5 years, and aggressive NHL type. Conclusion: Despite good functional recovery and adjustment in the community, NHL survivors report the presence of ongoing residual impairments and cognitive issues, which requires long-term rehabili-tation-inclusive management.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] HLA homozygosity is associated with Non-Hodgkin lymphoma
    Roark, Christina L.
    Ho, Bethany E.
    Aubrey, Michael T.
    Anobile, Cheri
    Israeli, Sapir
    Phang, Tzu L.
    Braxton, Danielle
    Ho, Andrea P.
    Freed, Brian M.
    HUMAN IMMUNOLOGY, 2022, 83 (10) : 730 - 735
  • [32] Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma
    Frey, Connor
    Etminan, Mahyar
    LEUKEMIA & LYMPHOMA, 2025,
  • [33] Infectious diseases and immunological markers associated with patients with non-Hodgkin lymphoma treated with rituximab
    de Souza, Kleber Jordao
    Ferro, Rodrigo Sala
    Prestes-Carneiro, Luiz Euribel
    Martins Carrilho, Paula Andreia
    Vasconcelos, Dewton de Moraes
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2018, 40 (01) : 13 - 17
  • [34] Long-term social dysfunction after trauma: What is the prevalence, risk factors, and associated outcomes?
    Herrera-Escobar, Juan P.
    Rivero, Rachel
    Apoj, Michel
    Geada, Alexandra
    Villanyi, Matthew
    Blake, David
    Nehra, Deepika
    Velmahos, George
    Kaafarani, Haytham M. A.
    Salim, Ali
    Haider, Adil H.
    Kasotakis, George
    SURGERY, 2019, 166 (03) : 392 - 397
  • [35] Long-Term Follow-Up of Patients with Non-Hodgkin and Hodgkin Lymphomas with a Modified BEAM Conditioning Regimen
    Armillas, Flor
    Leon, Eucario
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S251 - S251
  • [36] Psycho-oncological healthcare needs of patients with non-Hodgkin's lymphoma
    Labouvie, Hildegard
    Hellmich, Silke
    Fath, Birgit
    Hallek, Michael
    Kusch, Michael
    ONKOLOGE, 2019, 25 (10): : 914 - 918
  • [37] Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin Lymphoma
    Uchida, Mayako
    Mori, Yasuhiro
    Akiba, Kenta
    Miyasaka, Moena
    Hirano, Tatsuya
    Ikesue, Hiroaki
    Yamaguchi, Yuki
    Takano, Aoi
    Maegawa, Nami
    Shimomura, Yoshimitsu
    Hosohata, Keiko
    Muroi, Nobuyuki
    Ishikawa, Takayuki
    Hashida, Tohru
    Nakamura, Tsutomu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (10) : 1577 - 1582
  • [38] The Experience of Illness in Non-Hodgkin Lymphoma Patients
    Kim, Hye Sook
    Yi, Myungsun
    ASIAN ONCOLOGY NURSING, 2016, 16 (03) : 121 - 131
  • [39] Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors
    Zhan, Zhumei
    Guo, Wei
    Wan, Xin
    Bai, Ou
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 249 - 259
  • [40] Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: Effect of histological grade and follicular international prognostic index
    Vose, Julie M.
    Bierman, Philip J.
    Loberiza, Fansto R.
    Lynch, James C.
    Bociek, Gregoiy R.
    Weisenburger, Dennis D.
    Armitage, James O.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 36 - 42